Skip to main content
Douglas Golenbock, MD, Infectious Disease, Worcester, MA

DouglasTGolenbockMD

Infectious Disease • Worcester, MA

Physician

Join to view full profile

Dr. Golenbock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Golenbock's full profile

Already have an account?

  • Office

    119 Belmont St
    Worcester, MA 01605
    Phone+1 508-334-6053
    Fax+1 508-334-6412

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 1984 - 1988
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 1980 - 1983
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1990 - 2025
  • WI State Medical License
    WI State Medical License 1984 - 1991
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1997

Publications & Presentations

PubMed

Journal Articles

  • Targeting the IL33–NLRP3 Axis Improves Therapy for Experimental Cerebral Malaria  
    Douglas Golenbock, MD, Proceedings of the National Academy of Sciences

Press Mentions

  • Dean Lane to 57 New Doctoral Candidates: Collaboration Key to Science
    Dean Lane to 57 New Doctoral Candidates: Collaboration Key to ScienceSeptember 15th, 2021
  • UMass Chan Medical School Convocation 2021 Will Celebrate Scholarship and Education
    UMass Chan Medical School Convocation 2021 Will Celebrate Scholarship and EducationSeptember 8th, 2021
  • Amherst Board of Health to Require Face Coverings Indoors Effective Aug. 18
    Amherst Board of Health to Require Face Coverings Indoors Effective Aug. 18August 13th, 2021
  • Join now to see all

Grant Support

  • Innate Immune Mechanisms Governing Subclinical Malaria in ChildrenCASE WESTERN RESERVE UNIVERSITY2022–2026
  • Innate Immune Mechanisms Governing Subclinical Malaria in ChildrenCASE WESTERN RESERVE UNIVERSITY2022–2026
  • Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tractUNIV OF MASSACHUSETTS MED SCH WORCESTER2021–2026
  • Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tractUNIV OF MASSACHUSETTS MED SCH WORCESTER2021–2026
  • Inflammasome activation in modulation of Alzheimer's Disease by alcoholBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Inflammasome activation in modulation of Alzheimer's Disease by alcoholBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Innate Immune Activation in MalariaUNIV OF MASSACHUSETTS MED SCH WORCESTER2009–2025
  • Phagocyte Receptors For Lipid ANational Institute Of General Medical Sciences2008–2012
  • Group B. Streptococci And Toll-Like ReceptorsNational Institute Of Allergy And Infectious Diseases2002–2012
  • Role Of PSTPIP1 In A Mouse Model Of PAPA SyndromeNational Institute Of Allergy And Infectious Diseases2011
  • The TLR4/MD-2 Signaling Pathway In Gonoccocal DiseaseNational Institute Of Allergy And Infectious Diseases2009–2011
  • Mechanisms Of TLR 9 ActivationNational Institute Of Allergy And Infectious Diseases2005–2009
  • Mehanism Of TLR2 Activation By LCMVNational Institute Of Allergy And Infectious Diseases2004–2008
  • Group B. Streptococci And Toll-Like ReceptorsNational Institute Of Allergy And Infectious Diseases2007
  • Phagocyte Receptors For Lipid ANational Institute Of General Medical Sciences2001–2007
  • Tlr-Based Therapeutic Vaccine For P Falciparum MalariaNational Institute Of Allergy And Infectious Diseases2004–2005
  • Biology Of Chlamydia And Gonococcal Lipid ANational Institute Of Allergy And Infectious Diseases1995–2002
  • Flourescent Activated Cell SorterNational Center For Research Resources2001
  • Phagocyte Receptors For Lipid ANational Institute Of General Medical Sciences1998–2001
  • Phagocyte Receptors For Lipid ANational Institute Of General Medical Sciences1997
  • Lipid A And Membrane Protein InteractionsNational Institute Of General Medical Sciences1993–1996
  • Chlamydia And The Molecular Basis Of Phagocyte ActivationNational Institute Of Allergy And Infectious Diseases1993–1994
  • Lipid A And Membrane Protein InteractionsNational Institute Of General Medical Sciences1992
  • Chlamydia And The Molecular Basis Of Phagocyte ActivationNational Institute Of Allergy And Infectious Diseases1992
  • Lipid A Metabolism And Membrane Protein InteractionsNational Institute Of Allergy And Infectious Diseases1991
  • Lipid A Metabolism And Membrane Protein InteractionsNational Institute Of Allergy And Infectious Diseases1990
  • Lipid A Metabolism And Membrane Protein InteractionsNational Institute Of Allergy And Infectious Diseases1987–1989

Dr. Douglas Golenbock, Dr. Douglas Golenbock, MD, Dr. D Golenbock, Dr. Douglas T Golenbock